Guobin Wu

1.4k total citations
35 papers, 909 citations indexed

About

Guobin Wu is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Guobin Wu has authored 35 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Guobin Wu's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (9 papers) and RNA modifications and cancer (6 papers). Guobin Wu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (9 papers) and RNA modifications and cancer (6 papers). Guobin Wu collaborates with scholars based in China and United Kingdom. Guobin Wu's co-authors include Mengchao Wu, Jian Zhao, Rongyun Mai, Anmin Liang, Yajun Guo, Jiazhou Ye, Bin Lü, Le‐Qun Li, Jianxin Dai and Bin Lu and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Guobin Wu

33 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guobin Wu China 16 448 270 254 249 184 35 909
Lynda Aoudjehane France 14 297 0.7× 145 0.5× 316 1.2× 210 0.8× 176 1.0× 36 952
Kinya Okamoto Japan 19 282 0.6× 204 0.8× 443 1.7× 435 1.7× 182 1.0× 47 1.0k
Chung-Ta Lee Taiwan 15 420 0.9× 307 1.1× 80 0.3× 124 0.5× 197 1.1× 37 866
Peixiang Lan China 17 489 1.1× 165 0.6× 115 0.5× 231 0.9× 246 1.3× 34 1.2k
Kira Bettermann Austria 9 545 1.2× 424 1.6× 240 0.9× 301 1.2× 125 0.7× 11 983
Hiroyuki Fuke Japan 14 274 0.6× 82 0.3× 299 1.2× 225 0.9× 110 0.6× 38 746
Yun Gao China 16 407 0.9× 248 0.9× 115 0.5× 170 0.7× 381 2.1× 33 1.1k
Hengjun Gao China 18 399 0.9× 344 1.3× 193 0.8× 171 0.7× 253 1.4× 50 931
Teruyuki Ueda Japan 10 350 0.8× 286 1.1× 328 1.3× 226 0.9× 182 1.0× 21 830

Countries citing papers authored by Guobin Wu

Since Specialization
Citations

This map shows the geographic impact of Guobin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin Wu more than expected).

Fields of papers citing papers by Guobin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guobin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin Wu. The network helps show where Guobin Wu may publish in the future.

Co-authorship network of co-authors of Guobin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Guobin Wu. A scholar is included among the top collaborators of Guobin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guobin Wu. Guobin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hongyang, Dandan Zeng, Rong Liang, et al.. (2025). Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 2407–2419.
2.
Zeng, Jie, Yan Lin, Rong Liang, et al.. (2025). A CART-based prognostic model for risk stratification of postoperative early recurrence in hepatocellular carcinoma with microvascular invasion. Frontiers in Oncology. 15. 1655739–1655739.
3.
Ye, Jiazhou, et al.. (2024). Up-regulated ITGB4 promotes hepatocellular carcinoma metastasis by activating hypoxia-mediated glycolysis and cancer-associated fibroblasts. European Journal of Pharmacology. 986. 177102–177102. 3 indexed citations
4.
5.
Qiu, Jiang, Mian Wang, Guobin Wu, et al.. (2023). Organ-quarantined therapy: in situ normothermic machine perfusion of the renal allograft in a patient with a kidney transplant and an abdominal aortic aneurysm. British journal of surgery. 110(8). 998–999. 1 indexed citations
6.
Wu, Guobin, et al.. (2023). Application of clinical and CT imaging features in the evaluation of disease progression in patients with COVID-19. BMC Pulmonary Medicine. 23(1). 329–329. 2 indexed citations
7.
Lin, Yan, Xiaoli Liao, Yumei Zhang, et al.. (2022). Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy. Frontiers in Pharmacology. 13. 920939–920939. 3 indexed citations
8.
Chen, Zefeng, et al.. (2021). The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy. Frontiers in Cellular and Infection Microbiology. 10. 595759–595759. 57 indexed citations
9.
Wang, Min, et al.. (2020). Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma. BMC Cancer. 20(1). 1136–1136. 20 indexed citations
10.
Mai, Rongyun, Tao Bai, Rong Liang, et al.. (2020). Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Surgery. 168(4). 643–652. 42 indexed citations
11.
Mai, Rongyun, Jie Zeng, Rong Liang, et al.. (2020). Combining Aspartate Aminotransferase-to-Platelet Ratio Index with Future Liver Remnant to Assess Preoperative Hepatic Functional Reserve in Patients with Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery. 25(3). 688–697. 9 indexed citations
12.
Ye, Jiazhou, Zhibo Xie, Tao Bai, et al.. (2016). Postoperative adjuvant transarterial chemoembolization after curative resection reduces early recurrence of hepatocellular carcinoma. Zhonghua gan-dan waike zazhi. 22(4). 217–222. 1 indexed citations
13.
Huang, Chao‐Yuan, Xinping Huang, Jiye Zhu, et al.. (2015). miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. Oncology Reports. 33(6). 2889–2898. 73 indexed citations
14.
Zhu, Jiye, Shan Huang, Guobin Wu, et al.. (2015). Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 60(10). 3019–3031. 26 indexed citations
15.
Chen, Zhigang, Jiye Zhu, Chao‐Yuan Huang, et al.. (2015). The Association between Three Cyclooxygenase-2 Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis. PLoS ONE. 10(3). e0118251–e0118251. 8 indexed citations
16.
Wu, Guobin, Chao‐Yuan Huang, Shan Huang, et al.. (2014). Primary hepatic non-Hodgkin’s lymphoma with rectal cancer: A case report. Oncology Letters. 9(1). 324–326. 2 indexed citations
17.
Lu, Bin, Huaizu Guo, Jian Zhao, et al.. (2010). Increased Expression of iASPP, Regulated by Hepatitis B Virus X Protein-Mediated NF-κB Activation, in Hepatocellular Carcinoma. Gastroenterology. 139(6). 2183–2194.e5. 41 indexed citations
18.
Lü, Bin, Guobin Wu, Xin Tong, et al.. (2008). Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma. Clinical Cancer Research. 14(22). 7405–7412. 39 indexed citations
19.
Zhao, Jian, Bin Lu, Guobin Wu, et al.. (2008). Down-Regulation of Osteopontin Suppresses Growth and Metastasis of Hepatocellular Carcinoma Via Induction of Apoptosis. Gastroenterology. 135(3). 956–968. 116 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynda Aoudjehane Breakdown of academic impact, for papers by Kinya Okamoto Breakdown of academic impact, for papers by Chung-Ta Lee Breakdown of academic impact, for papers by Peixiang Lan Breakdown of academic impact, for papers by Kira Bettermann Breakdown of academic impact, for papers by Hiroyuki Fuke Breakdown of academic impact, for papers by Yun Gao Breakdown of academic impact, for papers by Hengjun Gao Breakdown of academic impact, for papers by Teruyuki Ueda
Rankless by CCL
2026